Last reviewed · How we verify
Placebo to match BTDS — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo to match BTDS (Placebo to match BTDS) — Purdue Pharma LP. This drug is a placebo that matches BTDS, meaning it has no active pharmacological effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo to match BTDS TARGET | Placebo to match BTDS | Purdue Pharma LP | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo to match BTDS CI watch — RSS
- Placebo to match BTDS CI watch — Atom
- Placebo to match BTDS CI watch — JSON
- Placebo to match BTDS alone — RSS
Cite this brief
Drug Landscape (2026). Placebo to match BTDS — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-btds. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab